Renal Cancer - Results from #5280

Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy March 25, 2017

Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients March 25, 2017

[Management of Toxicities of Immune Checkpoint Inhibitors] March 24, 2017

Clear Cell Renal Cell Carcinoma with Intratumoral Granulomatous Reaction: A Case Report and Review of the Literature March 24, 2017

Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents March 24, 2017

Comprehensive assessment of renal tumor complexity in a large percutaneous cryoablation cohort March 23, 2017

[Nephropathy in Patients Undergoing Cancer Drug Therapy - Platinum Derivatives(Cisplatin and Carboplatin)] March 23, 2017

The Role of High Dose Interleukin-2 in the Era of Targeted Therapy March 23, 2017

Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma March 22, 2017

Reproducibility and interobserver agreement of the R.E.N.A.L. nephrometry score: focus on imaging features March 22, 2017

Human mass balance study and metabolite profiling of (14)C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer March 21, 2017

Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions March 21, 2017

Economic evaluation of nivolumab as a second-line treatment for advanced renal cell carcinoma from US and Chinese perspectives March 21, 2017

Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms March 21, 2017

Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study. March 21, 2017

Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study March 20, 2017

Overall survival of 1st-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study March 20, 2017

[Pulmonary metastasectomy in renal cell carcinoma] March 18, 2017

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial March 17, 2017

Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy March 16, 2017

Page 265 of 456